We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
+$1.26B
Cap. Flow
-$390M
Cap. Flow %
-14.37%
Top 10 Hldgs %
63.11%
Holding
138
New
54
Increased
15
Reduced
11
Closed
39
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$109M
2
AMGN icon
Amgen
AMGN
+$53.5M
3
CELG
Celgene Corp
CELG
+$30.6M
4
FDC
First Data Corporation
FDC
+$27.3M
5
TFC icon
Truist Financial
TFC
+$23.2M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$62.5M
2
SHPG
Shire pic
SHPG
+$38M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$36.9M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$33.7M
5
SEND
SendGrid, Inc.
SEND
+$28.9M

Sector Composition

Rank Sector Weight
1 Miscellaneous 78.7%
2 Healthcare 7.97%
3 Technology 6.1%
4 Communication Services 2.23%
5 Financials 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$812B
$339M 12.49%
+1,200,000
New +$326M
2019 Q1
0 quarters
QCOM icon
2
PUT
Qualcomm
QCOM
$187B
$179M 6.61%
3,146,500
+1,099,400
+54% +$59.3M
2018 Q4
1 quarter
ICPT
3
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$162M 5.97%
1,449,900
+615,300
+74% +$67.2M
2018 Q2
3 quarters
AMGN icon
4
PUT
Amgen
AMGN
$237B
$160M 5.9%
+843,100
New +$161M
2019 Q1
0 quarters
BIIB icon
5
PUT
Biogen
BIIB
$35B
$82M 3.02%
+346,800
New +$109M
2019 Q1
0 quarters
BIIB icon
6
Biogen
BIIB
$35B
$82M 3.02%
+346,700
New +$109M
2019 Q1
0 quarters
MDCO
7
PUT
DELISTED
Medicines Co
MDCO
$65.3M 2.4%
2,334,800
+887,800
+61% +$20.9M
2018 Q1
4 quarters
QCOM icon
8
CALL
Qualcomm
QCOM
$187B
$61.2M 2.25%
+1,072,800
New +$57.9M
2019 Q1
0 quarters
AMGN icon
9
Amgen
AMGN
$237B
$53.2M 1.96%
+280,220
New +$53.5M
2019 Q1
0 quarters
LLL
10
DELISTED
L3 Technologies, Inc.
LLL
$46.7M 1.72%
226,058
+50,000
+28% +$9.9M
2018 Q4
1 quarter
ABBV icon
11
PUT
AbbVie
ABBV
$509B
$40.3M 1.48%
+500,000
New +$40.9M
2019 Q1
0 quarters
CELG
12
DELISTED
Celgene Corp
CELG
$33M 1.22%
+350,000
New +$30.6M
2019 Q1
0 quarters
RHT
13
DELISTED
Red Hat Inc
RHT
$31.1M 1.14%
170,000
+15,000
+10% +$2.69M
2018 Q4
1 quarter
FDC
14
DELISTED
First Data Corporation
FDC
$30.2M 1.11%
+1,150,000
New +$27.3M
2019 Q1
0 quarters
ULTI icon
15
DELISTED
Ultimate Software Group Inc
ULTI
$23.1M 0.85%
+70,000
New +$21.5M
2019 Q1
0 quarters
TFC icon
16
Truist Financial
TFC
$57B
$22.1M 0.81%
+474,695
New +$23.2M
2019 Q1
0 quarters
QCOM icon
17
Qualcomm
QCOM
$187B
$19.5M 0.72%
341,251
-1,157,431
-77% -$62.5M
2018 Q4
1 quarter
AABA
18
DELISTED
Altaba Inc
AABA
$18.5M 0.68%
250,000
+68,618
+38% +$4.72M
2018 Q4
1 quarter
ITCI icon
19
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.3M 0.67%
1,503,100
-725,400
-33% -$9.27M
2017 Q4
5 quarters
USG icon
20
DELISTED
Usg
USG
$18.2M 0.67%
420,000
+22,598
+6% +$975K
2018 Q2
3 quarters
ONCE
21
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$14.8M 0.55%
+130,000
New +$9.55M
2019 Q1
0 quarters
BMY icon
22
CALL
Bristol-Myers Squibb
BMY
$125B
$14.3M 0.53%
+300,000
New +$14.9M
2019 Q1
0 quarters
GG
23
DELISTED
Goldcorp Inc
GG
$13.7M 0.51%
+1,200,000
New +$12.9M
2019 Q1
0 quarters
IDTI
24
DELISTED
Integrated Device Technology I
IDTI
$13.2M 0.49%
270,000
-90,000
-25% -$4.36M
2018 Q3
2 quarters
WP
25
DELISTED
Worldpay, Inc.
WP
$11.8M 0.44%
+104,400
New +$9.47M
2019 Q1
0 quarters
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, DLD Asset Management held 138 positions worth $2.72B, up 86% from $1.46B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

DLD Asset Management withdrew a net $390M in Q1 2019, closing 39 positions and reducing 11 holdings. Its most notable exit was Shire pic, an estimated $38M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 67% a quarter earlier, followed by Healthcare and Technology.

Against the trend, DLD Asset Management opened a new position in Biogen worth $82M.

  • DLD Asset Management's largest Q1 2019 buy was Biogen: 346,700 shares worth $82M.
  • DLD Asset Management added most to L3 Technologies, Inc. in Q1 2019, an estimated $9.9M increase.
  • DLD Asset Management's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $62.5M.
  • DLD Asset Management fully exited Shire pic in Q1 2019, selling an estimated $38M.
  • DLD Asset Management's ten largest holdings make up 63% of its $2.72B portfolio in Q1 2019.
  • DLD Asset Management opened 54 new positions and closed 39 in Q1 2019.
  • DLD Asset Management's portfolio value rose 86% quarter-over-quarter to $2.72B.

Based on DLD Asset Management's 13F filing for Q1 2019, filed 14 May 2019.